Avanafil CAS: 330784-47-9

CAS NO: 330784-47-9
Avanafil
Chemical Name: Avanafil
Molecular Formula: C23H26ClN7O3
Formula Weight: 483.95
CAS No.: 330784-47-9
Description Review
Description

Avanafil (CAS: 330784-47-9) is a medication used in the treatment of erectile dysfunction (ED), a condition that affects millions of men worldwide. It belongs to the class of phosphodiesterase type 5 (PDE5) inhibitors and has been shown to be effective in improving sexual function.

Chemical Name:

4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyridinylmethyl)-5-pyrimidinecarboxamide

Molecular Formula:

C23H26ClN7O3

Formula Weight:

483.96 g/mol

CAS No:

330784-47-9

Top Ten Keywords from Google and Synonyms:

  1. Avanafil
  2. Erectile Dysfunction
  3. PDE5 Inhibitor
  4. Sexual Function
  5. CAS: 330784-47-9
  6. Stendra
  7. Impotence Treatment
  8. Erection
  9. Nitric Oxide
  10. Phosphodiesterase Type 5

Synonyms:

  • GSK-33259
  • STENDRA
  • 4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2S,3R)-2-hydroxy-3-(pyrrolidin-1-yl)propyl]-N-(pyridin-2-ylmethyl)pyrimidine-5-carboxamide

Health Benefits of this Product:

Avanafil is primarily used in the treatment of ED, a common condition that can significantly impact quality of life. Its ability to improve sexual function has been shown to have positive effects on relationships and overall well-being.

Potential Effects:

Avanafil works by inhibiting PDE5, an enzyme that breaks down cyclic guanosine monophosphate (cGMP), a molecule involved in the relaxation of smooth muscle tissue in the penis. By inhibiting PDE5, avanafil increases levels of cGMP, leading to improved blood flow and enhanced erectile function.

Product Mechanism:

Avanafil works by inhibiting PDE5, an enzyme that breaks down cyclic guanosine monophosphate (cGMP), a molecule involved in the relaxation of smooth muscle tissue in the penis.

Safety:

As with all medications, proper precautions should be taken to ensure safe administration, and patients should be monitored closely for any potential side effects or adverse reactions.

Side Effects:

Common side effects of avanafil include headache, flushing, and nasal congestion. Rare but serious side effects may include sudden hearing loss or vision changes. Patients should be monitored regularly for potential side effects and seek medical attention if symptoms occur.

Dosing Information:

The recommended dose of avanafil varies depending on the patient's individual needs and medical history. Consult a healthcare professional for specific dosing information.

Conclusion:

Avanafil is a valuable tool in the management of ED, offering targeted therapy that has been proven effective in improving sexual function and enhancing quality of life. While proper precautions should be taken to ensure safe administration, the proven efficacy and safety profile of avanafil make it a valuable development in the field of impotence treatment. Its unique mode of action targeting PDE5 also offers potential for the treatment of other conditions in the future

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code